Synergy Pharmaceuticals Appoints Paul Eng, Ph.D., As Senior Vice President, Drug Development
5/29/2014 7:31:40 AM
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the appointment of Paul Eng, Ph.D., as Senior Vice President, Drug Development. Dr. Eng will lead all clinical development operations for Synergy’s pivotal phase 3 program with plecanatide in patients with irritable bowel syndrome with constipation (IBS-C).
Help employers find you! Check out all the jobs and post your resume.
comments powered by